Here are three stocks with buy rank and strong value characteristics for investors to consider today, July 27th:
AerCap Holdings N.V. (AER - Free Report) : This aircraft leasing company has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.
Aercap Holdings N.V. Price and Consensus
AerCap has a price-to-earnings ratio (P/E) of 8.74 compared with 13.90 for the industry. The company possesses a Value Score of A.
Aercap Holdings N.V. PE Ratio (TTM)
Nucor Corporation (NUE - Free Report) : This seller of steel products has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings climbing 20.5% over the last 60 days.
Nucor Corporation Price and Consensus
Nucor has a price-to-earnings ratio (P/E) of 9.40 compared with 11.50 for the industry. The company possesses a Value Score of A.
Nucor Corporation PE Ratio (TTM)
OneMain Holdings, Inc. (OMF - Free Report) : This provider of consumer finance services has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
OneMain Holdings, Inc. Price and Consensus
OneMain has a price-to-earnings ratio (P/E) of 7.12, compared with 8.80 for the industry. The company possesses a Value Score of A.
OneMain Holdings, Inc. PE Ratio (TTM)
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong value characteristics for investors to consider today, July 27th:
AerCap Holdings N.V. (AER - Free Report) : This aircraft leasing company has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.
Aercap Holdings N.V. Price and Consensus
AerCap has a price-to-earnings ratio (P/E) of 8.74 compared with 13.90 for the industry. The company possesses a Value Score of A.
Aercap Holdings N.V. PE Ratio (TTM)
Nucor Corporation (NUE - Free Report) : This seller of steel products has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings climbing 20.5% over the last 60 days.
Nucor Corporation Price and Consensus
Nucor has a price-to-earnings ratio (P/E) of 9.40 compared with 11.50 for the industry. The company possesses a Value Score of A.
Nucor Corporation PE Ratio (TTM)
OneMain Holdings, Inc. (OMF - Free Report) : This provider of consumer finance services has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
OneMain Holdings, Inc. Price and Consensus
OneMain has a price-to-earnings ratio (P/E) of 7.12, compared with 8.80 for the industry. The company possesses a Value Score of A.
OneMain Holdings, Inc. PE Ratio (TTM)
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on NUE - FREE
Get the latest research report on AER - FREE
Get the latest research report on OMF - FREE